Zeta pharma

Zeta pharma® was established in 2010 to represent an added value in the pharmaceutical industry in Egypt through: • Establishing one of the best manufacturing facilities in the Middle East referenced by the international standards (GMP). • Building a well selected and unique product portfolio in the main therapeutic areas, which ensure that community has the most efficient and up-to-date treatment that directly contributes to improve health care and quality of their life. Beginning in 2015, Zeta pharma® actively contribute to treat Hepatitis C virus in Egypt through its products: 1. Sofocivir™ 2. Zetaciver™ 3. Sofocivir plus™ With collaboration with the Egyptian Ministry of Health and Egyptian Liver Research Institute, Zeta pharma® has managed to treat more than 60,000 patients with healing rates 95 % similar to those of global rate Starting in 2017, Zeta pharma® began to export its products to the countries of Eastern Europe after the great success achieved in the local market. Beginning in 2018 the Zeta pharma® launched many of its top line products in GIT & CVM therapeutic areas. Zeta pharma® is targeting to launch more than 60 drugs over the next three years in private and tender sector Zeta pharma® team covers all the Egypt’s governorates , also Zeta pharma® is seeking to open new markets in Middle East –Africa region